PLoS ONE (Jan 2017)
Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0061939.].
PLoS ONE (Jan 2017)
[This corrects the article DOI: 10.1371/journal.pone.0061939.].